Ciltacabtagene autoleucel

Definition: Ciltacabtagene autoleucel, sold under the brand name Carvykti, is an anti-cancer medication used to treat multiple myeloma. Ciltacabtagene autoleucel is a BCMA (B-cell maturation antigen)-directed genetically modified autologous chimeric antigen receptor (CAR) T-cell therapy. Each dose is customized using the recipient's own T-cells, which are collected, genetically modified, and infused back into the recipient. source: Wikipedia

ID

1370976008

ID date

6 Oct 2025

Previous ID

44122711000001109

Name

Ciltacabtagene autoleucel